Logo image of ALCBI.PA

CRYPTO BLOCKCHAIN INDUSTRIES (ALCBI.PA) Stock Fundamental Analysis

EPA:ALCBI - Euronext Paris - Matif - FR0014007LW0 - Common Stock - Currency: EUR

0.1415  -0.01 (-5.67%)

Fundamental Rating

2

Overall ALCBI gets a fundamental rating of 2 out of 10. We evaluated ALCBI against 99 industry peers in the Software industry. ALCBI has a bad profitability rating. Also its financial health evaluation is rather negative. ALCBI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALCBI has reported negative net income.
In the past year ALCBI has reported a negative cash flow from operations.
ALCBI had positive earnings in 4 of the past 5 years.
Of the past 5 years ALCBI 4 years had a positive operating cash flow.
ALCBI.PA Yearly Net Income VS EBIT VS OCF VS FCFALCBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.64%, ALCBI is doing worse than 61.62% of the companies in the same industry.
ALCBI's Return On Equity of -5.81% is in line compared to the rest of the industry. ALCBI outperforms 41.41% of its industry peers.
Industry RankSector Rank
ROA -3.64%
ROE -5.81%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCBI.PA Yearly ROA, ROE, ROICALCBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

In the last couple of years the Operating Margin of ALCBI has declined.
ALCBI has a Gross Margin of 69.05%. This is comparable to the rest of the industry: ALCBI outperforms 46.46% of its industry peers.
In the last couple of years the Gross Margin of ALCBI has declined.
The Profit Margin and Operating Margin are not available for ALCBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.05%
OM growth 3Y-60.1%
OM growth 5Y-42.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.84%
GM growth 5Y-6.03%
ALCBI.PA Yearly Profit, Operating, Gross MarginsALCBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

ALCBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALCBI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALCBI.PA Yearly Shares OutstandingALCBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1B 2B 3B
ALCBI.PA Yearly Total Debt VS Total AssetsALCBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 1.31, we must say that ALCBI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.31, ALCBI is doing worse than 62.63% of the companies in the same industry.
ALCBI has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
ALCBI has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. ALCBI outperforms 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACCN/A
WACC7.88%
ALCBI.PA Yearly LT Debt VS Equity VS FCFALCBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.41 indicates that ALCBI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.41, ALCBI perfoms like the industry average, outperforming 58.59% of the companies in the same industry.
ALCBI has a Quick Ratio of 1.19. This is a normal value and indicates that ALCBI is financially healthy and should not expect problems in meeting its short term obligations.
ALCBI has a Quick ratio (1.19) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.19
ALCBI.PA Yearly Current Assets VS Current LiabilitesALCBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M

2

3. Growth

3.1 Past

The earnings per share for ALCBI have decreased strongly by -236.59% in the last year.
The Revenue for ALCBI has decreased by -25.66% in the past year. This is quite bad
The Revenue has been growing by 49.67% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-236.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-126.67%
Revenue 1Y (TTM)-25.66%
Revenue growth 3Y102.2%
Revenue growth 5Y49.67%
Sales Q2Q%-7.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALCBI.PA Yearly Revenue VS EstimatesALCBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALCBI.PA Yearly EPS VS EstimatesALCBI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

ALCBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCBI.PA Price Earnings VS Forward Price EarningsALCBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCBI.PA Per share dataALCBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06 0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALCBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CRYPTO BLOCKCHAIN INDUSTRIES

EPA:ALCBI (3/7/2025, 7:00:00 PM)

0.1415

-0.01 (-5.67%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners78.14%
Ins Owner ChangeN/A
Market Cap37.18M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.5
P/FCF N/A
P/OCF N/A
P/B 1.5
P/tB 4.8
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.01
BVpS0.09
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.64%
ROE -5.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.05%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-60.1%
OM growth 5Y-42.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.84%
GM growth 5Y-6.03%
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 385.56%
Cap/Sales 11.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.19
Altman-Z 1.31
F-Score2
WACC7.88%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)122.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-236.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-126.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.66%
Revenue growth 3Y102.2%
Revenue growth 5Y49.67%
Sales Q2Q%-7.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-135.69%
EBIT growth 3Y-19.33%
EBIT growth 5Y-14.66%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-660.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-419.63%
OCF growth 3YN/A
OCF growth 5YN/A